WO1999041408A1 - Microbial assay - Google Patents

Microbial assay Download PDF

Info

Publication number
WO1999041408A1
WO1999041408A1 PCT/GB1999/000438 GB9900438W WO9941408A1 WO 1999041408 A1 WO1999041408 A1 WO 1999041408A1 GB 9900438 W GB9900438 W GB 9900438W WO 9941408 A1 WO9941408 A1 WO 9941408A1
Authority
WO
WIPO (PCT)
Prior art keywords
atp
microorganisms
membrane
adenylate kinase
microbial
Prior art date
Application number
PCT/GB1999/000438
Other languages
French (fr)
Inventor
Nicholas Peter Martin Foote
Robert Beeton
Nicola Jane Bodsworth
Nigel Kyle
Original Assignee
Celsis International Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celsis International Plc filed Critical Celsis International Plc
Priority to AU25332/99A priority Critical patent/AU2533299A/en
Publication of WO1999041408A1 publication Critical patent/WO1999041408A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase

Definitions

  • This invention relates to an assay, and in particular to a rapid microbial counting method.
  • ATP bioluminescence is gaining widespread acceptance in the field of microbiology as a rapid means of detecting microbial contamination.
  • ATP released from microorganisms is made to produce light in a reaction mediated by the luciferase enzyme from fireflies, and the emitted light is detected with great sensitivity by a luminometer.
  • the result is normally displayed as a relative light unit (RLU) value; the higher the figure, the more ATP was present in the sample.
  • RLU relative light unit
  • Kits are available commercially for applications such as hygiene monitoring (detecting both microorganisms and organic dirt), presence/absence testing (in which a test sample is incubated in an enrichment broth until any organisms present multiply to detectable levels), and total viable estimation (the RLU value is related to the number of microorganisms present).
  • WO-A-9319199 describes a test method in which a filterable test sample, suspected to contain a low number of microorganisms, is divided amongst a series of compartments of equal volume. Enrichment broth is then added to each. After a suitable incubation period, the compartments are assayed individually for microbial growth, by means of ATP bioluminescence. A bioluminescence signal greater than a given threshold value indicates that a compartment originally contained at least one viable microorganism; by comparing the number of compartments giving a positive result with the total, a "most probable number" of organisms in the test sample is calculated.
  • this method overcomes the inaccuracy normally associated with ATP bioluminescence by physical division of the test sample, after which a presence/absence test is performed on each sub-sample.
  • the assay is commercially available from Celsis Limited as the Digital system, which uses a microtitre plate with a membrane filter on the base of each well for the sample division step.
  • the incubation step is at least 24 hours for most sample types, as this is the length of time needed for a single stressed microorganism to recover and multiply to a detectable level. It would be a great advantage for industrial microbiologists to have a "same-shift" (i.e. less than 8 hours) test, as this would allow more timely corrective action if a contamination problem occurs.
  • EP-A-0529084 A second approach is disclosed in EP-A-0529084. This is based on membrane filtration. Organisms trapped by the membrane are subjected to an ATP bioluminescence assay, using reagents delivered as fine sprays.
  • the membrane comprises a large number of hydrophilic areas separated by hydrophobic partitions so that liquids are confined within the partitions, and the light emitted from a trapped microorganism can be detected as a small spot with an imaging system.
  • the quantification problems associated with ATP bioluminescence are avoided by making use of spatial resolution across the membrane, and the number of light-emitting spots can be related to the viable microbial load of the sample. This is commercially available through Millipore Inc. as the Microstar system.
  • ATP bioluminescence is not the most sensitive method for rapid microbial detection.
  • WO-A-9417202 claims the use of adenylate kinase (AK) as a target for microbial assays.
  • AK adenylate kinase
  • This ubiquitous enzyme can be made to convert two molecules of adenosine 5'-diphosphate (ADP) to a molecule each of adenosine 5'-triphosphate (ATP) and adenosine ⁇ '-monophosphate (AMP), after which the ATP can be detected luminometrically using the firefly luciferase reaction.
  • ADP adenosine 5'-diphosphate
  • ATP adenosine 5'-triphosphate
  • AMP adenosine ⁇ '-monophosphate
  • the microbial adenylate kinase will make a far greater amount of ATP than was present originally in the microorganism; in effect, this method gives an amplification of ATP bioluminescence.
  • Summary of the Invention The present invention is based on the finding that the microbial adenylate kinase reaction, and subsequent emission of bioluminescence, can be made to take place on a membrane filter, thereby giving a more quantitative determination of microbial contamination.
  • a method for the detection of microorganisms comprises retaining the microorganisms on a substrate and permeabilising the microorganisms without destroying endogenous adenylate kinase, adding ADP, and determining the presence of ATP.
  • an assay according to the invention comprises the following steps: (1) Filtration of the test sample through a hydrophilic membrane filter with hydrophobic partitions.
  • Step (1 ) Analysis of the membrane with an imaging system, to give a count of glowing spots, each of which corresponds to a microorganism or clump of microorganisms in the original sample.
  • Step (1 ) is sufficient to ensure that the microorganisms in a sample to be tested are retained on the membrane, during subsequent steps of the process. During subsequent steps, it is desirable to ensure that there is no mixing of the contents of the adjacent zones defined by the partitions.
  • an additional incubation period on a nutrient medium may be required between steps (1) and (2) above: for instance, when the sample contains microbial spores which must be made to germinate before they can be detected, or when extremely stressed or starved microorganisms are present.
  • the ADP is preferably highly purified. Commercial preparations contain ATP at levels of 0.1% or greater. This may give a high background signal during the bioluminescence step. Therefore, ATP may be removed essentially completely, e.g. by ion-exchange chromatography.
  • the detergent or detergent mixture should be harsh enough to permeabilise a wide range of microorganisms when they are trapped on a membrane filter, yet not interfere significantly with the activity of adenylate kinase. This can be determined by one of ordinary skill in the art. Suitable detergents are well known. Specific conditions are illustrated in the Examples, and useful/optimum levels of retained AK activity can readily be determined by experiment.
  • the bioluminescence reagent is preferably essentially free of contaminating adenylate kinase. For example, this is achieved using dye-ligand chromatography.
  • the bioluminescence reagent preferably provides a steady or slowly-decaying light signal. This can be achieved despite the presence of cell-permeabilising detergents which tend to inactivate firefly luciferase.
  • Example 1 illustrates the invention.
  • This Example demonstrates that a bioluminescence signal can be generated by the action of adenylate kinase from microorganisms captured on a membrane filter, and that the signal can be used for rapid microbial enumeration.
  • the membrane- handling devices, hand-held nebuliserfor reagent delivery, imaging system and image analysis software comprise the Microstar system (Millipore Inc.) which has been designed to detect microorganisms by their ATP content.
  • Saccharomyces cerevisiae was grown to stationary phase in broth and then diluted in sterile Maximum Recovery Diluent to approximately 160 cfu/ml (determined by parallel agar plate counts).0.1 ml of this dilution (expected to contain approximately 16 yeast cells) was then added to 20 ml of sterile water and passed through a hydrophilic membrane filter with hydrophobic partitions (Millipore Inc.).
  • the membrane was allowed to dry under sterile laminar flow for approximately 20 minutes, placed in a metal filter holder, and then sprayed with a detergent mixture (Microcount ATP Releasing Agent, Millipore Inc., at double concentration) containing 0.1 mM purified ADP, 10 mM magnesium acetate and 2.5 mM potassium phosphate, pH 6.5.
  • a detergent mixture Mocrocount ATP Releasing Agent, Millipore Inc., at double concentration
  • the membrane was maintained for 15 minutes under laminar flow. During this time, ATP was generated by microbial adenylate kinase.
  • the membrane was subsequently dried and then sprayed with a low-AK bioluminescence reagent and placed in the imaging system. The image was collected for 2 minutes and the number of bright spots calculated by the image analysis software.
  • a suspension of Escherichia coli was prepared in maximum recovery diluent.
  • the membrane was allowed to dry under sterile laminar flow, placed in a metal filter holder, and then sprayed with a 1:2 mixture of microbial adenylate kinase assay reagent (MAKAR) and microbial collection and dilution solution (MCDS) (both reagents are available from Celsis Limited).-
  • MAKAR microbial adenylate kinase assay reagent
  • MCDS microbial collection and dilution solution
  • the membrane After being allowed to dry again under laminar flow, the membrane was sprayed with low-ATP bioluminescence reagent and placed in the imaging system for analysis.
  • a series of 31 purified water samples obtained from 2 pharmaceutical production sites was analysed by the adenylate kinase method and by reference plate counts.
  • Suitable sample volumes were diluted where necessary into 50 ml of sterile water and analysed by the adenylate kinase method and by reference plate counts.
  • the membranes were incorporated into the Milliflex disposable filter holder system (Millipore Inc.) which allows the funnel to be snapped off after filtration and holds the membrane filter within a plastic ring device.
  • the adenylate kinase assays were performed as for Example 2 except that the membrane was placed on a Milliflex R2A cassette (Millipore Inc.) at 30 °C for 2 hours immediately following filtration. This step aids germination of any spores in the sample and may help to increase the signal from stressed organisms.
  • the reagents were applied by air-driven spray devices rather than ultrasonic nebulisers.
  • the chosen reference method was incubation for between 5 and 7 days at 30°C on R2A cassettes. Results are shown in Figure 1. This is a graph of adenylate kinase MPN plotted against reference plate count (RPC). Because there is a tendency at higher microbial levels for more than one organism to be collected in one of the approximately 450 squares formed by the hydrophobic grid, the adenylate kinase results have been converted to MPN values using the formula
  • n is the uncorrected number of bright spots counted by the image analysis software.
  • the graph shows the line of equivalence as a solid line.
  • Bacterial spores cannot be detected by the adenylate kinase method until they have been exposed to nutrients and allowed to germinate, but no spore-forming organisms were found in the water samples using conventional identification techniques.

Abstract

A method for the detection of microorganisms, comprises retaining the microorganisms on a substrate and permeabilising the microorganisms without destroying endogenous adenylate kinase, adding ADP, and determining the presence of ATP.

Description

1
MICROBIAL ASSAY Field of the Invention
This invention relates to an assay, and in particular to a rapid microbial counting method. Background of the Invention
ATP bioluminescence is gaining widespread acceptance in the field of microbiology as a rapid means of detecting microbial contamination. ATP released from microorganisms is made to produce light in a reaction mediated by the luciferase enzyme from fireflies, and the emitted light is detected with great sensitivity by a luminometer. The result is normally displayed as a relative light unit (RLU) value; the higher the figure, the more ATP was present in the sample.
Kits are available commercially for applications such as hygiene monitoring (detecting both microorganisms and organic dirt), presence/absence testing (in which a test sample is incubated in an enrichment broth until any organisms present multiply to detectable levels), and total viable estimation (the RLU value is related to the number of microorganisms present).
The latter approach has drawbacks. It is well known that different microbial species, even in a healthy physiological state, can contain very different amounts of ATP. In addition, when a microorganism is stressed or damaged, as is likely in most test samples, it will have an appreciably lower ATP level. This can lead to considerable inaccuracy when it is attempted to correlate RLU values with microbial numbers measured and with a reference method such as an agar plate count.
Several ways of circumventing this issue have been suggested and two have led to commercial products. WO-A-9319199 describes a test method in which a filterable test sample, suspected to contain a low number of microorganisms, is divided amongst a series of compartments of equal volume. Enrichment broth is then added to each. After a suitable incubation period, the compartments are assayed individually for microbial growth, by means of ATP bioluminescence. A bioluminescence signal greater than a given threshold value indicates that a compartment originally contained at least one viable microorganism; by comparing the number of compartments giving a positive result with the total, a "most probable number" of organisms in the test sample is calculated. Therefore, this method overcomes the inaccuracy normally associated with ATP bioluminescence by physical division of the test sample, after which a presence/absence test is performed on each sub-sample. The assay is commercially available from Celsis Limited as the Digital system, which uses a microtitre plate with a membrane filter on the base of each well for the sample division step. The incubation step is at least 24 hours for most sample types, as this is the length of time needed for a single stressed microorganism to recover and multiply to a detectable level. It would be a great advantage for industrial microbiologists to have a "same-shift" (i.e. less than 8 hours) test, as this would allow more timely corrective action if a contamination problem occurs.
A second approach is disclosed in EP-A-0529084. This is based on membrane filtration. Organisms trapped by the membrane are subjected to an ATP bioluminescence assay, using reagents delivered as fine sprays. The membrane comprises a large number of hydrophilic areas separated by hydrophobic partitions so that liquids are confined within the partitions, and the light emitted from a trapped microorganism can be detected as a small spot with an imaging system. The quantification problems associated with ATP bioluminescence are avoided by making use of spatial resolution across the membrane, and the number of light-emitting spots can be related to the viable microbial load of the sample. This is commercially available through Millipore Inc. as the Microstar system. It will count yeast cells directly but bacteria, which contain very much less ATP, require an enrichment step of several hours after filtration, before they can reliably be detected. ATP bioluminescence is not the most sensitive method for rapid microbial detection. WO-A-9417202 claims the use of adenylate kinase (AK) as a target for microbial assays. This ubiquitous enzyme can be made to convert two molecules of adenosine 5'-diphosphate (ADP) to a molecule each of adenosine 5'-triphosphate (ATP) and adenosine δ'-monophosphate (AMP), after which the ATP can be detected luminometrically using the firefly luciferase reaction. During a reaction time of a few minutes, the microbial adenylate kinase will make a far greater amount of ATP than was present originally in the microorganism; in effect, this method gives an amplification of ATP bioluminescence. Summary of the Invention The present invention is based on the finding that the microbial adenylate kinase reaction, and subsequent emission of bioluminescence, can be made to take place on a membrane filter, thereby giving a more quantitative determination of microbial contamination.
According to the present invention, a method for the detection of microorganisms, comprises retaining the microorganisms on a substrate and permeabilising the microorganisms without destroying endogenous adenylate kinase, adding ADP, and determining the presence of ATP. Description of the Invention
Preferably, an assay according to the invention comprises the following steps: (1) Filtration of the test sample through a hydrophilic membrane filter with hydrophobic partitions.
(2) Treatment of the membrane with a reagent containing detergents (to permeabilise microbial cells) and ADP.
(3) Incubation of the membrane, typically for a few minutes, in order to allow production of ATP by the microbial adenylate kinase.
(4) Treatment of the membrane with a luciferase-luciferin reagent.
(5) Analysis of the membrane with an imaging system, to give a count of glowing spots, each of which corresponds to a microorganism or clump of microorganisms in the original sample. Step (1 ) is sufficient to ensure that the microorganisms in a sample to be tested are retained on the membrane, during subsequent steps of the process. During subsequent steps, it is desirable to ensure that there is no mixing of the contents of the adjacent zones defined by the partitions.
In some cases, an additional incubation period on a nutrient medium may be required between steps (1) and (2) above: for instance, when the sample contains microbial spores which must be made to germinate before they can be detected, or when extremely stressed or starved microorganisms are present.
The ADP is preferably highly purified. Commercial preparations contain ATP at levels of 0.1% or greater. This may give a high background signal during the bioluminescence step. Therefore, ATP may be removed essentially completely, e.g. by ion-exchange chromatography.
The detergent or detergent mixture should be harsh enough to permeabilise a wide range of microorganisms when they are trapped on a membrane filter, yet not interfere significantly with the activity of adenylate kinase. This can be determined by one of ordinary skill in the art. Suitable detergents are well known. Specific conditions are illustrated in the Examples, and useful/optimum levels of retained AK activity can readily be determined by experiment.
The bioluminescence reagent is preferably essentially free of contaminating adenylate kinase. For example, this is achieved using dye-ligand chromatography. The bioluminescence reagent preferably provides a steady or slowly-decaying light signal. This can be achieved despite the presence of cell-permeabilising detergents which tend to inactivate firefly luciferase.
The following Examples illustrate the invention. Example 1
This Example demonstrates that a bioluminescence signal can be generated by the action of adenylate kinase from microorganisms captured on a membrane filter, and that the signal can be used for rapid microbial enumeration. The membrane- handling devices, hand-held nebuliserfor reagent delivery, imaging system and image analysis software comprise the Microstar system (Millipore Inc.) which has been designed to detect microorganisms by their ATP content.
Saccharomyces cerevisiae was grown to stationary phase in broth and then diluted in sterile Maximum Recovery Diluent to approximately 160 cfu/ml (determined by parallel agar plate counts).0.1 ml of this dilution (expected to contain approximately 16 yeast cells) was then added to 20 ml of sterile water and passed through a hydrophilic membrane filter with hydrophobic partitions (Millipore Inc.). The membrane was allowed to dry under sterile laminar flow for approximately 20 minutes, placed in a metal filter holder, and then sprayed with a detergent mixture (Microcount ATP Releasing Agent, Millipore Inc., at double concentration) containing 0.1 mM purified ADP, 10 mM magnesium acetate and 2.5 mM potassium phosphate, pH 6.5.
The membrane was maintained for 15 minutes under laminar flow. During this time, ATP was generated by microbial adenylate kinase. The membrane was subsequently dried and then sprayed with a low-AK bioluminescence reagent and placed in the imaging system. The image was collected for 2 minutes and the number of bright spots calculated by the image analysis software.
The above was performed in duplicate. As a comparison, duplicate membranes were taken through the same procedure but without the inclusion of ADP in the first reagent (so that the assay would detect only the intrinsic microbial ATP, and not the additional ATP generated by the reaction of adenylate kinase). Results were as follows. Detection Method Counts Detected
AK 16
19
ATP 0
0
Figure imgf000007_0001
Example 2
A suspension of Escherichia coli was prepared in maximum recovery diluent.
0.05 ml aliquots were then diluted into 50 ml of sterile water and then immediately passed through 0.45 μm cellulose nitrate membrane filters and placed onto tryptone soya agar plates (for reference plate counts) or passed through membrane filters with hydrophobic grids.
For the adenylate kinase assay, the membrane was allowed to dry under sterile laminar flow, placed in a metal filter holder, and then sprayed with a 1:2 mixture of microbial adenylate kinase assay reagent (MAKAR) and microbial collection and dilution solution (MCDS) (both reagents are available from Celsis Limited).- The membrane filter was then placed in a sterile plastic Petri dish which was left in a plastic box containing moist tissue for 20 minutes at 37 °C. The membrane was then dried under laminar flow. This procedure ensures that the membrane remains damp during the adenylate kinase reaction step.
After being allowed to dry again under laminar flow, the membrane was sprayed with low-ATP bioluminescence reagent and placed in the imaging system for analysis.
The mean number of spots detected by the adenylate kinase assay, which took less than 1 hour to perform, was 38. The mean plate result for the reference method, counted after 3 days, was 35. Example 3
A series of 31 purified water samples obtained from 2 pharmaceutical production sites was analysed by the adenylate kinase method and by reference plate counts.
Suitable sample volumes were diluted where necessary into 50 ml of sterile water and analysed by the adenylate kinase method and by reference plate counts. In both cases, the membranes were incorporated into the Milliflex disposable filter holder system (Millipore Inc.) which allows the funnel to be snapped off after filtration and holds the membrane filter within a plastic ring device.
The adenylate kinase assays were performed as for Example 2 except that the membrane was placed on a Milliflex R2A cassette (Millipore Inc.) at 30 °C for 2 hours immediately following filtration. This step aids germination of any spores in the sample and may help to increase the signal from stressed organisms. In addition, the reagents were applied by air-driven spray devices rather than ultrasonic nebulisers. The chosen reference method was incubation for between 5 and 7 days at 30°C on R2A cassettes. Results are shown in Figure 1. This is a graph of adenylate kinase MPN plotted against reference plate count (RPC). Because there is a tendency at higher microbial levels for more than one organism to be collected in one of the approximately 450 squares formed by the hydrophobic grid, the adenylate kinase results have been converted to MPN values using the formula
MPN = -450 x ln (1-t?/450)
where n is the uncorrected number of bright spots counted by the image analysis software. The graph shows the line of equivalence as a solid line. Clearly there is a high degree of correspondence between the adenylate kinase MPN results, obtained within 3 hours of sample filtration, and the reference plate counts after 5 days or more. It is likely that data points lying significantly above the line of equivalence represent samples containing organisms that could be detected by the adenylate kinase content, but could not grow to visible colonies under the conditions of the reference method. Example 4
27 of the 31 samples used for Example 3 were tested using a similar adenylate kinase assay method but without the 2-hour recovery step on R2A. The results are shown in Figure 2. The degree of correspondence with the reference method is similar to Example 3, but in this case the adenylate kinase assay took less than 1 hour to perform.
Bacterial spores cannot be detected by the adenylate kinase method until they have been exposed to nutrients and allowed to germinate, but no spore-forming organisms were found in the water samples using conventional identification techniques.

Claims

1. A method for the detection of microorganisms, which comprises retaining the microorganisms on a substrate and permeabilising the microorganisms without destroying endogenous adenylate kinase, adding ADP, and determining the presence of ATP.
2. A method according to claim 1 , wherein the determining is by bioluminescence.
3. A method according to claim 1 or claim 2, wherein the added ADP is essentially free of ATP.
4. A method according to any preceding claim, wherein the microorganisms are present in one or more discrete areas of an assay device.
5. A method according to any preceding claim, wherein the substrate is a membrane filter having zones defined by hydrophobic partitions.
PCT/GB1999/000438 1998-02-13 1999-02-12 Microbial assay WO1999041408A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25332/99A AU2533299A (en) 1998-02-13 1999-02-12 Microbial assay

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9803156.0 1998-02-13
GBGB9803156.0A GB9803156D0 (en) 1998-02-13 1998-02-13 Assay

Publications (1)

Publication Number Publication Date
WO1999041408A1 true WO1999041408A1 (en) 1999-08-19

Family

ID=10826992

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/000438 WO1999041408A1 (en) 1998-02-13 1999-02-12 Microbial assay

Country Status (3)

Country Link
AU (1) AU2533299A (en)
GB (1) GB9803156D0 (en)
WO (1) WO1999041408A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2348438A (en) * 1999-03-19 2000-10-04 David Anthony Stafford Detecting microbes by bioluminescence
US6599711B2 (en) 2000-12-15 2003-07-29 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
EP1333097A2 (en) * 2002-02-01 2003-08-06 Celsis International PLC Polyols in bioluminescence assays
US6949351B1 (en) 1999-05-13 2005-09-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Cell assay, method and reagents
WO2007113583A1 (en) * 2006-04-05 2007-10-11 Alaska Food Diagnostics Limited Method for detecting microorganism
US7585644B2 (en) 2003-04-17 2009-09-08 Cambrex Bio Science Nottingham, Ltd. Mycopolasma detecting methods and materials

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017202A1 (en) * 1993-01-21 1994-08-04 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological test method and reagents
WO1996002665A1 (en) * 1994-07-13 1996-02-01 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological test method and reagents
WO1996002666A1 (en) * 1994-07-13 1996-02-01 The Secretary Of State For Defence Capture assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017202A1 (en) * 1993-01-21 1994-08-04 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological test method and reagents
WO1996002665A1 (en) * 1994-07-13 1996-02-01 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological test method and reagents
WO1996002666A1 (en) * 1994-07-13 1996-02-01 The Secretary Of State For Defence Capture assays

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2348438A (en) * 1999-03-19 2000-10-04 David Anthony Stafford Detecting microbes by bioluminescence
US6949351B1 (en) 1999-05-13 2005-09-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Cell assay, method and reagents
US6599711B2 (en) 2000-12-15 2003-07-29 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
US6911319B2 (en) 2000-12-15 2005-06-28 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
EP1333097A2 (en) * 2002-02-01 2003-08-06 Celsis International PLC Polyols in bioluminescence assays
EP1333097A3 (en) * 2002-02-01 2004-01-14 Celsis International PLC Polyols in bioluminescence assays
US7585644B2 (en) 2003-04-17 2009-09-08 Cambrex Bio Science Nottingham, Ltd. Mycopolasma detecting methods and materials
WO2007113583A1 (en) * 2006-04-05 2007-10-11 Alaska Food Diagnostics Limited Method for detecting microorganism

Also Published As

Publication number Publication date
GB9803156D0 (en) 1998-04-08
AU2533299A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
US3745090A (en) Method of detecting and counting bacteria in body fluids
US3933592A (en) Method of detecting living microorganisms
AU2005217026B2 (en) Measuring contamination
AU677627B2 (en) Microbiological test method and reagents
US5236827A (en) Device for enhancing fluorescence and kinetics and methods of using the device
GB1604249A (en) Selective measurement of somatic and microbial cells
AU616957B2 (en) Device for enhancing fluorescence and kinetics and methods of using the device
US11085065B2 (en) Phenotypic engineering of spores
WO2007139601A2 (en) Phenotypic engineering of spore
CN101233244A (en) Improved methods of detecting viability-associated molecules
AU630549B2 (en) Identifying microorganisms by measuring enzymatic activity in the presence of enzyme activity affecting agents
Singh et al. Evaluation of biomass
EP1134291A1 (en) Method for counting living cells
WO1999041408A1 (en) Microbial assay
Tanaka et al. Development and application of a bioluminescence ATP assay method for rapid detection of coliform bacteria
JP5189722B2 (en) Compositions and methods for target microbial detection in samples
CA2306211C (en) Methods for the rapid detection of viable bacteria
JP2003180395A (en) Method for detecting microorganism
US8148081B2 (en) Method for detecting microorganisms on a membrane
WO1996038584A1 (en) Assay for microorganisms
JP3607327B2 (en) Rapid detection of single microbial cells
Tsai et al. Rapid separation and quantitation of mixed microorganisms by filtration and bioluminescence
JP2000279195A (en) New method for analyzing intracellular constituent and reagent kit
Nandy Comparative Studies on CFU Determination by Pure and/or Mixed Culture Cultivations
Lindström ATP-based monitoring system for CIP rinse waters in enzyme industry

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase